American Century Companies’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
RCMNY
CP
American Century Companies's ADMA Position: Q2 2026 in Review
American Century Companies reduced its ADMA Biologics (ADMA) stake by 95% in Q2 2026, selling an estimated $41.6M and leaving 226,518 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2212.
American Century Companies first reported a position in ADMA in Q1 2023 and has held it in 14 quarters since. The position peaked at $94.8M in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.
- American Century Companies held 226,518 shares of ADMA Biologics worth $1.9M as of Q2 2026.
- American Century Companies sold 4,562,493 ADMA Biologics shares in Q2 2026, an estimated $41.6M.
- ADMA Biologics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2212 holding.
- American Century Companies first reported a position in ADMA Biologics in Q1 2023 and has held it in 14 quarters since.
- American Century Companies's ADMA Biologics position peaked at $94.8M in Q4 2025.
- 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.